TrialEuropean heart journal2025

Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.

Michael Böhm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.